AnHeart and Innovent Releases Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach